|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
03-22-2010, 01:39 PM
|
|||
|
|||
Syngene in pact with Endo Pharma to develop anti-cancer novel molecules (PharmaBiz)
Syngene International, a subsidiary of Biocon has entered into a discovery and development collaboration with Endo Pharmaceuticals USA to develop novel biological therapeutic molecules against cancer.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Moffitt Cancer Center and GLG Pharma, LLC sign licensing agreement to develop the nex | cancerfr | Latest Cancer News | 0 | 09-23-2010 10:49 PM |
| Jennerex, Transgene enter pact to develop & commercialise JX-594 in Europe, CIS & Mid | cancerfr | Extracranial Germ Cell Tumor | 0 | 09-10-2010 03:47 AM |
| Access Pharma inks exclusive specialty distribution pact with BioScrip | cancerfr | Oral Cancer | 0 | 07-22-2010 11:41 AM |
| Access Pharma inks collaborative development pact with bioRASI for oral insulin produ | cancerfr | Oral Cancer | 0 | 04-05-2010 12:29 PM |
| Chugai Pharma seeks Japanese additional approval for anti-cancer agents Herceptin & X | cancerfr | Oral Cancer | 0 | 03-21-2010 11:40 AM |
Linear Mode
